Medicines, Poisons and Therapeutic Goods Regulation 2026
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Medicines, Poisons and Therapeutic Goods Regulation 2026
Start here
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2026.
172 Recording of information for database by authorised practitioners
(1) This section applies to an authorised practitioner who uses an electronic prescribing system connected to a prescription exchange service operated by a data source entity (a prescriber).
(2) A prescriber who issues a prescription for a monitored medicine must, for the purposes of the database, record the following information—
(a) the full name of the prescriber,
(b) the prescriber’s registration number or code recorded in the National Register, as referred to in the Health Practitioner Regulation National Law, section 225(c),
(c) the healthcare identifier for the prescriber and the prescriber’s practice, if available,
(d) the contact information for the prescriber and the prescriber’s practice, including telephone number or email address,
(e) other approved information about the prescriber or the prescriber’s practice,
(f) the date on which the prescription is issued,
(g) the information required to be included in the prescription under sections 50(1) and (2) and 54,
(h) the full name, sex, date of birth and street address of the person to whom the prescription is issued,
(i) other approved information about the person to whom the prescription is issued.
(3) A prescriber who issues a prescription for a monitored medicine may, for the purposes of the database, record the following information about the person to whom the prescription is issued—
(a) the healthcare identifier,
(b) other approved information.